Stock Analysis on Net

Boston Scientific Corp. (NYSE:BSX)

$22.49

This company has been moved to the archive! The financial data has not been updated since May 4, 2023.

DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
Quarterly Data

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Two-Component Disaggregation of ROE

Boston Scientific Corp., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = ROA × Financial Leverage
Mar 31, 2023 = ×
Dec 31, 2022 = ×
Sep 30, 2022 = ×
Jun 30, 2022 = ×
Mar 31, 2022 = ×
Dec 31, 2021 = ×
Sep 30, 2021 = ×
Jun 30, 2021 = ×
Mar 31, 2021 = ×
Dec 31, 2020 = ×
Sep 30, 2020 = ×
Jun 30, 2020 = ×
Mar 31, 2020 = ×
Dec 31, 2019 = ×
Sep 30, 2019 = ×
Jun 30, 2019 = ×
Mar 31, 2019 = ×

Based on: 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).


The quarterly financial data reveals several notable trends relating to the profitability and financial structure of the company over the analyzed period.

Return on Assets (ROA)
The ROA exhibited a fluctuating pattern across the quarters. Starting at 7.55% in March 2019, it declined steadily to a low of 4.07% by September 2019. A sharp increase followed, peaking at 15.38% in December 2019. This was succeeded by a general downward trend, turning negative at -0.27% in December 2020. Subsequent quarters showed a modest recovery, with ROA reaching 3.62% by September 2021 but then stabilizing around 2% to 2.75% through early 2023. Overall, ROA shows initial volatility and a significant dip in late 2020, with moderate recovery later.
Financial Leverage
The financial leverage ratio demonstrated a gradual and consistent decline over the entire timeline. Beginning at 2.58 in March 2019, the ratio decreased to around 2.2 by December 2019, then fluctuated slightly but generally trended downward to 1.84 by March 2023. This suggests a steady reduction in the use of debt relative to equity, indicating a conservative approach to financial risk over time.
Return on Equity (ROE)
ROE followed a trend somewhat similar to ROA but with more pronounced changes. Starting at 19.46% in March 2019, it declined to 11.24% by September 2019 before rising sharply to a peak of 33.87% in December 2019. This was followed by a steep decrease, plunging into negative territory at -0.54% in December 2020. Recovery ensued, with ROE increasing steadily to 7.02% in September 2021, then exhibiting some fluctuations but generally remaining between approximately 3.7% and 6.26% through early 2023. This pattern indicates significant volatility in returns to shareholders, with a notable peak at the end of 2019 and a marked downturn coinciding with the negative ROA period.

In summary, the data reflects periods of high profitability and return, especially at the end of 2019, followed by notable declines in 2020, likely influenced by external or operational factors. The financial leverage trend indicates reduced reliance on debt financing, which may have implications for financial stability and cost of capital. The recovery in profitability metrics after their decline remains moderate, reflecting ongoing challenges to achieving prior peak performance levels.


Three-Component Disaggregation of ROE

Boston Scientific Corp., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Net Profit Margin × Asset Turnover × Financial Leverage
Mar 31, 2023 = × ×
Dec 31, 2022 = × ×
Sep 30, 2022 = × ×
Jun 30, 2022 = × ×
Mar 31, 2022 = × ×
Dec 31, 2021 = × ×
Sep 30, 2021 = × ×
Jun 30, 2021 = × ×
Mar 31, 2021 = × ×
Dec 31, 2020 = × ×
Sep 30, 2020 = × ×
Jun 30, 2020 = × ×
Mar 31, 2020 = × ×
Dec 31, 2019 = × ×
Sep 30, 2019 = × ×
Jun 30, 2019 = × ×
Mar 31, 2019 = × ×

Based on: 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).


Net Profit Margin
The net profit margin exhibited significant fluctuation over the observed periods. Initially, it declined from 18.08% in the first quarter of 2019 to 10.49% by the third quarter of 2019, followed by a sharp increase to a peak of 43.78% at the end of 2019. Subsequently, the margin decreased considerably in 2020, reaching a negative value of -0.83% in the final quarter of 2020. From 2021 onwards, the net profit margin showed a recovery trend but remained below the earlier peaks, stabilizing in a range between approximately 5% and 10%, indicating moderate profitability.
Asset Turnover
The asset turnover ratio demonstrated a gradual decline from 0.42 in early 2019 to a low of 0.32 in the last quarter of 2020, indicating a slight reduction in the efficiency of using assets to generate sales during this period. Following this, the ratio experienced a steady recovery, rising to 0.4 by the first quarter of 2023, reflecting an improvement in asset utilization over the recent quarters.
Financial Leverage
Financial leverage decreased consistently throughout the timeframe, moving from 2.58 in early 2019 to 1.84 by the first quarter of 2023. This trend suggests a gradual reduction in the use of debt relative to equity, potentially indicating a more conservative capital structure and possibly lower financial risk over time.
Return on Equity (ROE)
Return on equity followed a pattern similar to net profit margin, declining from 19.46% in early 2019 to 11.24% by the third quarter of 2019, then surging to 33.87% at the end of 2019. It subsequently dropped sharply to negative territory at -0.54% in the final quarter of 2020. Afterward, ROE showed gradual recovery but remained subdued compared to the earlier peak, increasing to just above 5% in early 2023. This suggests that shareholders' profitability diminished notably during the middle period before beginning to improve moderately.
Summary of Trends
In summary, profitability indicators such as net profit margin and return on equity showed pronounced volatility with peaks toward the end of 2019 and troughs around late 2020. Both metrics indicate a strong performance followed by a period of challenges and a subsequent partial recovery. The efficiency of asset utilization decreased during the initial periods but improved gradually in recent quarters. Meanwhile, the consistent reduction in financial leverage reflects a strategic shift toward lower reliance on debt financing. These trends collectively suggest a period of operational and financial adjustment, with signs of stabilization and incremental improvement in profitability and asset efficiency as of the most recent quarters.

Five-Component Disaggregation of ROE

Boston Scientific Corp., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Financial Leverage
Mar 31, 2023 = × × × ×
Dec 31, 2022 = × × × ×
Sep 30, 2022 = × × × ×
Jun 30, 2022 = × × × ×
Mar 31, 2022 = × × × ×
Dec 31, 2021 = × × × ×
Sep 30, 2021 = × × × ×
Jun 30, 2021 = × × × ×
Mar 31, 2021 = × × × ×
Dec 31, 2020 = × × × ×
Sep 30, 2020 = × × × ×
Jun 30, 2020 = × × × ×
Mar 31, 2020 = × × × ×
Dec 31, 2019 = × × × ×
Sep 30, 2019 = × × × ×
Jun 30, 2019 = × × × ×
Mar 31, 2019 = × × × ×

Based on: 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).


The analysis of the quarterly financial ratios reveals several notable trends over the observed periods. The tax burden ratio exhibits significant volatility with a pronounced spike in the early 2020 period, followed by a stabilization below 1.0 in the most recent quarters, indicating changes in tax expense relative to pretax income.

The interest burden ratio shows a considerable fluctuation, including a negative value in mid-2020 suggesting unusual financial circumstances or accounting adjustments during that period. However, it improves steadily thereafter, reaching more stable and positive values in recent quarters, which reflects improving earnings before interest and taxes relative to earnings before taxes.

The EBIT margin experienced a downward trend initially, reaching a low point at the end of 2020, followed by a gradual recovery in profitability. Despite the recovery, the margin remains below the levels observed in the earliest quarters, indicating varying operational efficiency or cost pressures affecting earnings before interest and taxes as a percentage of revenue.

Asset turnover has been relatively stable, with a slight declining trend early on that levels off in recent periods at around 0.39-0.40. This suggests consistency in how effectively the company utilizes its assets to generate sales, although there is limited improvement over time.

Financial leverage demonstrates a gradual decline from approximately 2.6 to below 1.9, implying a conservative shift in capital structure and potentially reduced reliance on debt financing. This trend may affect risk exposure and interest obligations related to the company's financial strategy.

Return on equity (ROE) shows a sharp increase during the end of 2019, peaking significantly, but then drops to a negative value in the final quarter of 2020, indicating a loss or substantial decline in net income relative to shareholder equity. Since then, ROE has shown modest recovery but remains relatively low compared to earlier highs, reflecting challenges in generating returns for shareholders consistently.

Tax Burden
Highly variable with an extreme peak in early 2020, followed by normalization below 1.0 in recent quarters.
Interest Burden
Fluctuated widely including negative values in 2020, improving steadily thereafter to positive and more stable levels.
EBIT Margin
Decreased steadily to a low point in late 2020 before recovering, yet remaining lower than earlier periods.
Asset Turnover
Stable with a slight downward trend initially, stabilizing near 0.39 to 0.40, indicating consistent asset usage.
Financial Leverage
Gradual reduction indicating less reliance on debt financing and reduced financial risk.
Return on Equity (ROE)
Experienced volatility with a sharp peak followed by substantial decline and partial recovery, remaining low in recent quarters.

Overall, the company demonstrates a period of financial strain around 2020 with recovery signs in operational margins and interest burden. However, profitability as measured by ROE has not fully rebounded to prior peak levels, while financial leverage has decreased steadily suggesting a strategic move towards reduced financial risk.


Two-Component Disaggregation of ROA

Boston Scientific Corp., decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Net Profit Margin × Asset Turnover
Mar 31, 2023 = ×
Dec 31, 2022 = ×
Sep 30, 2022 = ×
Jun 30, 2022 = ×
Mar 31, 2022 = ×
Dec 31, 2021 = ×
Sep 30, 2021 = ×
Jun 30, 2021 = ×
Mar 31, 2021 = ×
Dec 31, 2020 = ×
Sep 30, 2020 = ×
Jun 30, 2020 = ×
Mar 31, 2020 = ×
Dec 31, 2019 = ×
Sep 30, 2019 = ×
Jun 30, 2019 = ×
Mar 31, 2019 = ×

Based on: 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).


Net Profit Margin
The net profit margin exhibited considerable volatility over the analyzed period. Initially, it declined from 18.08% in the first quarter of 2019 to a low of 10.49% in the third quarter of the same year, followed by a sharp increase peaking at 43.78% in the fourth quarter of 2019. This was maintained at elevated levels through the first three quarters of 2020 before experiencing a significant plunge to -0.83% in the last quarter of 2020. Subsequently, a gradual recovery ensued, with the margin rising to 10.07% by the third quarter of 2021. However, from 2022 onwards, the margin settled at a more moderate range between 5.2% and 7.17%, ending at 6.91% in the first quarter of 2023, indicating stabilization after previous fluctuations.
Asset Turnover
The asset turnover ratio showed a general declining trend from 0.42 in the first quarter of 2019 to a trough of 0.32 in the last quarter of 2020. This decrease suggests a reduction in efficiency in utilizing assets to generate revenue during that timeframe. Beginning in the first quarter of 2021, the ratio demonstrated a mild but steady recovery, increasing to 0.40 by the first quarter of 2023. The overall movement indicates a return towards improved operational efficiency, though the ratio did not surpass initial 2019 levels within the observed period.
Return on Assets (ROA)
ROA trends mirrored those of net profit margin generally. It declined from 7.55% in early 2019 to 4.07% in the third quarter of the same year, then surged to a peak of 15.38% in the fourth quarter, followed by sustained high values in the first three quarters of 2020. The ratio drastically dropped to -0.27% in the fourth quarter of 2020, indicating negative returns on assets. A gradual recovery followed, but ROA remained subdued relative to earlier peaks, oscillating between approximately 0.8% and 3.62% through 2021. Throughout 2022 and into early 2023, the ROA stabilized at low positive levels around 2%, suggesting modest asset profitability in recent quarters.
Summary Insights
Across all three metrics, there was a notable spike in performance during late 2019 and early 2020, followed by a sharp decline towards the end of 2020. This pattern points to a period of robust profitability and efficiency succeeded by challenges impacting financial returns and operational productivity. Since 2021, gradual recovery and stabilization are evident, though profitability and asset utilization have not fully returned to previous highs. The data suggests cautious improvement in the company's financial health and activity efficiency after a turbulent period.

Four-Component Disaggregation of ROA

Boston Scientific Corp., decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover
Mar 31, 2023 = × × ×
Dec 31, 2022 = × × ×
Sep 30, 2022 = × × ×
Jun 30, 2022 = × × ×
Mar 31, 2022 = × × ×
Dec 31, 2021 = × × ×
Sep 30, 2021 = × × ×
Jun 30, 2021 = × × ×
Mar 31, 2021 = × × ×
Dec 31, 2020 = × × ×
Sep 30, 2020 = × × ×
Jun 30, 2020 = × × ×
Mar 31, 2020 = × × ×
Dec 31, 2019 = × × ×
Sep 30, 2019 = × × ×
Jun 30, 2019 = × × ×
Mar 31, 2019 = × × ×

Based on: 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).


The quarterly financial data indicates several notable trends in the key performance ratios over the observed periods.

Tax Burden
The Tax Burden ratio exhibited high volatility, starting at 1.15 in the first quarter of 2019 and peaking dramatically at 17.01 in the first quarter of 2020. After this spike, there is a gap in data before it stabilizes at lower levels around 1.11 in early 2021 and gradually declines to approximately 0.61 by the first quarter of 2023. This trend suggests fluctuating effective tax rates or tax impacts influencing profitability during these periods, followed by a steady improvement or normalization in recent quarters.
Interest Burden
The Interest Burden ratio shows a downward trend from 0.84 in March 2019 to negative values in the mid to latter part of 2020, reaching as low as -7.4 in September 2020, indicating significant interest expenses or financial costs burden during that time. However, it recovers from negative values to 0.85 by the first quarter of 2023, showing an improvement in managing interest costs or financing expenses over time.
EBIT Margin
The EBIT margin demonstrates a declining trajectory in 2019 and 2020, starting from 18.57% and dropping to as low as 0.52% in September 2020. Thereafter, an upward recovery trend is observed, with the margin increasing to near 13% by the first quarter of 2023. This pattern indicates that operational profitability faced significant pressure during the mid-2020 period but improved considerably afterward, reflecting enhanced earnings before interest and taxes in more recent quarters.
Asset Turnover
Asset turnover has shown minor fluctuations but generally maintains a stable range between 0.32 and 0.42 throughout the entire period. The slight decline in late 2019 and early 2020 is followed by a gradual increase, reflecting steady efficiency in generating revenue from assets with marginal improvements towards the latest quarter.
Return on Assets (ROA)
Return on Assets exhibits variability, starting at 7.55% in March 2019, falling to 4.07% by September 2019, then peaking sharply at 15.38% in the last quarter of 2019. However, ROA declines significantly afterwards, including a negative value of -0.27% in December 2020, before stabilizing at low positive returns of around 2.5% to 2.74% in the early 2023 period. This indicates fluctuating asset profitability influenced by operational and financial factors, with a weaker performance phase around 2020 and modest improvement in subsequent quarters.

In summary, the data presents a period of financial strain particularly in 2020 affecting interest cost management, tax burden, and operational profitability, followed by gradual recuperation across most key metrics. The company appears to have managed better cost control and improved returns in recent quarters, although asset utilization efficiency remains relatively constant throughout the observed timeframe.


Disaggregation of Net Profit Margin

Boston Scientific Corp., decomposition of net profit margin ratio (quarterly data)

Microsoft Excel
Net Profit Margin = Tax Burden × Interest Burden × EBIT Margin
Mar 31, 2023 = × ×
Dec 31, 2022 = × ×
Sep 30, 2022 = × ×
Jun 30, 2022 = × ×
Mar 31, 2022 = × ×
Dec 31, 2021 = × ×
Sep 30, 2021 = × ×
Jun 30, 2021 = × ×
Mar 31, 2021 = × ×
Dec 31, 2020 = × ×
Sep 30, 2020 = × ×
Jun 30, 2020 = × ×
Mar 31, 2020 = × ×
Dec 31, 2019 = × ×
Sep 30, 2019 = × ×
Jun 30, 2019 = × ×
Mar 31, 2019 = × ×

Based on: 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).


Tax Burden
The tax burden ratio shows substantial volatility over the periods analyzed. It remained close to unity from early 2019 through the first quarter of 2020, with a notable spike at the end of 2019 and first quarter of 2020 indicating increased tax impact or anomalies during that period. Following this peak, data for part of 2020 is missing but later resumed to values close to one from early 2021 onward. A gradual decline in the tax burden is observed from the first quarter of 2022 to the first quarter of 2023, suggesting a reduced tax impact over time.
Interest Burden
The interest burden ratio slightly declined throughout 2019, reaching a negative value by mid to late 2020, which indicates interest income exceeding interest expense or possible accounting adjustments during this period. After this phase of unusual negative figures, the ratio gradually improved toward positive values starting in early 2021, increasing steadily and reaching a relatively strong level by the first quarter of 2023. This trend suggests an overall improvement in earnings before interest relative to earnings before tax and interest burden fluctuations normalized following the mid-2020 period.
EBIT Margin
The EBIT margin showed a declining trend throughout 2019, dropping from 18.57% in the first quarter to a low of 0.52% by the third quarter of 2020. This decline may indicate weakening operating profitability. However, from late 2020 through the first quarter of 2023, a recovery is evident, with the EBIT margin climbing back upward and reaching around 13% by early 2023. The recovery is somewhat uneven but indicates improving operating efficiency and profitability after the mid-2020 trough.
Net Profit Margin
The net profit margin exhibits significant fluctuations during the periods reviewed. Starting at 18.08% in early 2019, it plunged and then sharply spiked at the end of 2019 and early 2020, reaching levels near 40%, possibly due to unusual items or one-time gains. The margin then collapsed to a negative value by the end of 2020, reflecting a loss. From early 2021 onwards, the net profit margin shows a steady but moderate recovery trend, climbing from 2.45% to nearly 7% by the first quarter of 2023. This pattern suggests a return to profitability but not yet reaching the pre-2019 peak levels.